{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:43Z","timestamp":1793296063948,"version":"4.5.0"},"reference-count":254,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41584-024-01190-w","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:25:39Z","timestamp":1733729139000},"page":"9-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The \u2018Treg paradox\u2019 in inflammatory arthritis"],"prefix":"10.1038","volume":"21","author":[{"given":"Julia T.","family":"Schnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2369-567X","authenticated-orcid":false,"given":"Raquel Laza","family":"Briviesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehyeung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Marie","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-1356","authenticated-orcid":false,"given":"Femke","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-3702","authenticated-orcid":false,"given":"Peter A.","family":"Nigrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"1190_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","volume":"38","author":"S Sakaguchi","year":"2020","unstructured":"Sakaguchi, S. et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 38, 541\u2013566 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"TA Chatila","year":"2000","unstructured":"Chatila, T. A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75\u201381 (2000).","journal-title":"J. Clin. Invest."},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18\u201320 (2001).","journal-title":"Nat. Genet."},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20\u201321 (2001).","journal-title":"Nat. Genet."},{"key":"1190_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368 (2014).","journal-title":"Nat. Med."},{"key":"1190_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141008","volume":"131","author":"A Levescot","year":"2021","unstructured":"Levescot, A. et al. IL-1\u03b2-driven osteoclastogenic Tregs accelerate bone erosion in arthritis. J. Clin. Invest. 131, e141008 (2021).","journal-title":"J. Clin. Invest."},{"key":"1190_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057\u20131061 (2003).","journal-title":"Science"},{"key":"1190_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"1190_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337\u2013342 (2003).","journal-title":"Nat. Immunol."},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","volume":"39","author":"P Georgiev","year":"2019","unstructured":"Georgiev, P., Charbonnier, L. M. & Chatila, T. A. Regulatory T cells: the many faces of Foxp3. J. Clin. Immunol. 39, 623\u2013640 (2019).","journal-title":"J. Clin. Immunol."},{"key":"1190_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nri3155","volume":"12","author":"CS Hsieh","year":"2012","unstructured":"Hsieh, C. S., Lee, H. M. & Lio, C. W. Selection of regulatory T cells in the thymus. Nat. Rev. Immunol. 12, 157\u2013167 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/ni.2554","volume":"14","author":"AK Abbas","year":"2013","unstructured":"Abbas, A. K. et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14, 307\u2013308 (2013).","journal-title":"Nat. Immunol."},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","volume":"259","author":"EM Shevach","year":"2014","unstructured":"Shevach, E. M. & Thornton, A. M. tTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259, 88\u2013102 (2014).","journal-title":"Immunol. Rev."},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.20060468","volume":"203","author":"N Seddiki","year":"2006","unstructured":"Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693\u20131700 (2006).","journal-title":"J. Exp. Med."},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701\u20131711 (2006).","journal-title":"J. Exp. Med."},{"key":"1190_CR17","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/eji.200839040","volume":"39","author":"P Milpied","year":"2009","unstructured":"Milpied, P. et al. Neuropilin-1 is not a marker of human Foxp3+ Treg. Eur. J. Immunol. 39, 1466\u20131471 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433\u20133441 (2010).","journal-title":"J. Immunol."},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.20120822","volume":"209","author":"M Yadav","year":"2012","unstructured":"Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713\u20131722 (2012).","journal-title":"J. Exp. Med."},{"key":"1190_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.20120914","volume":"209","author":"JM Weiss","year":"2012","unstructured":"Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723\u20131742 (2012).","journal-title":"J. Exp. Med."},{"key":"1190_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162306","volume":"11","author":"T Morita","year":"2016","unstructured":"Morita, T. et al. The proportion of regulatory T cells in patients with rheumatoid arthritis: a meta-analysis. PLoS ONE 11, e0162306 (2016).","journal-title":"PLoS ONE"},{"key":"1190_CR22","doi-asserted-by":"crossref","unstructured":"Go, E. et al. Peripheral blood from rheumatoid arthritis patients shows decreased Treg CD25 expression and reduced frequency of effector Treg subpopulation. Cells 10, 801 (2021).","DOI":"10.3390\/cells10040801"},{"key":"1190_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/imm.13115","volume":"158","author":"AM Thornton","year":"2019","unstructured":"Thornton, A. M. & Shevach, E. M. Helios: still behind the clouds. Immunology 158, 161\u2013170 (2019).","journal-title":"Immunology"},{"key":"1190_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024226","volume":"6","author":"T Akimova","year":"2011","unstructured":"Akimova, T., Beier, U. H., Wang, L., Levine, M. H. & Hancock, W. W. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 6, e24226 (2011).","journal-title":"PLoS ONE"},{"key":"1190_CR25","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.4049\/jimmunol.1402898","volume":"195","author":"P Hsu","year":"2015","unstructured":"Hsu, P. et al. IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1. J. Immunol. 195, 3665\u20133674 (2015).","journal-title":"J. Immunol."},{"key":"1190_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison, L. W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093\u20131101 (2010).","journal-title":"Nat. Immunol."},{"key":"1190_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2567.2001.01235.x","volume":"103","author":"CA Akdis","year":"2001","unstructured":"Akdis, C. A. & Blaser, K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 103, 131\u2013136 (2001).","journal-title":"Immunology"},{"key":"1190_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2017.03.015","volume":"46","author":"JE Konkel","year":"2017","unstructured":"Konkel, J. E. et al. Transforming growth factor-\u03b2 signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity 46, 660\u2013674 (2017).","journal-title":"Immunity"},{"key":"1190_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang, J., Zhao, X. & Wan, Y. Y. Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology. Cell. Mol. Immunol. 20, 1002\u20131022 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"1190_CR30","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/eji.200425274","volume":"34","author":"M de la Rosa","year":"2004","unstructured":"de la Rosa, M., Rutz, S., Dorninger, H. & Scheffold, A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480\u20132488 (2004).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","volume":"8","author":"P Pandiyan","year":"2007","unstructured":"Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. & Lenardo, M. J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353\u20131362 (2007).","journal-title":"Nat. Immunol."},{"key":"1190_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1190_CR33","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986\u2013991 (2009).","journal-title":"Science"},{"key":"1190_CR34","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20062129","volume":"204","author":"T Bopp","year":"2007","unstructured":"Bopp, T. et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303\u20131310 (2007).","journal-title":"J. Exp. Med."},{"key":"1190_CR35","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1073\/pnas.1009463108","volume":"108","author":"M Vaeth","year":"2011","unstructured":"Vaeth, M. et al. Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl Acad. Sci. USA 108, 2480\u20132485 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257\u20131265 (2007).","journal-title":"J. Exp. Med."},{"key":"1190_CR37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225\u20131232 (2007).","journal-title":"Blood"},{"key":"1190_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard, B., Longhi, M. S., Robson, S. C. & Stagg, J. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol. Rev. 276, 121\u2013144 (2017).","journal-title":"Immunol. Rev."},{"key":"1190_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271\u2013275 (2008).","journal-title":"Science"},{"key":"1190_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","volume":"332","author":"OS Qureshi","year":"2011","unstructured":"Qureshi, O. S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600\u2013603 (2011).","journal-title":"Science"},{"key":"1190_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fimmu.2012.00165","volume":"3","author":"M Kornete","year":"2012","unstructured":"Kornete, M. & Piccirillo, C. A. Functional crosstalk between dendritic cells and Foxp3+ regulatory T cells in the maintenance of immune tolerance. Front. Immunol. 3, 165 (2012).","journal-title":"Front. Immunol."},{"key":"1190_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","volume":"95","author":"P Kumar","year":"2018","unstructured":"Kumar, P., Bhattacharya, P. & Prabhakar, B. S. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity. J. Autoimmun. 95, 77\u201399 (2018).","journal-title":"J. Autoimmun."},{"key":"1190_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","volume":"21","author":"WJ Grossman","year":"2004","unstructured":"Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589\u2013601 (2004).","journal-title":"Immunity"},{"key":"1190_CR44","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","volume":"174","author":"DC Gondek","year":"2005","unstructured":"Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. & Noelle, R. J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783\u20131786 (2005).","journal-title":"J. Immunol."},{"key":"1190_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"1190_CR46","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","volume":"107","author":"DM Zhao","year":"2006","unstructured":"Zhao, D. M., Thornton, A. M., DiPaolo, R. J. & Shevach, E. M. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107, 3925\u20133932 (2006).","journal-title":"Blood"},{"key":"1190_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","volume":"34","author":"M Panduro","year":"2016","unstructured":"Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609\u2013633 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"1190_CR48","doi-asserted-by":"publisher","first-page":"717903","DOI":"10.3389\/fcell.2021.717903","volume":"9","author":"Q Shao","year":"2021","unstructured":"Shao, Q. et al. Tissue Tregs and maintenance of tissue homeostasis. Front. Cell Dev. Biol. 9, 717903 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1190_CR49","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.immuni.2024.05.023","volume":"57","author":"OT Burton","year":"2024","unstructured":"Burton, O. T. et al. The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program. Immunity 57, 1586\u20131602.e10 (2024).","journal-title":"Immunity"},{"key":"1190_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri.2015.18","volume":"16","author":"M DuPage","year":"2016","unstructured":"DuPage, M. & Bluestone, J. A. Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease. Nat. Rev. Immunol. 16, 149\u2013163 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1190_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","volume":"35","author":"Y Wang","year":"2011","unstructured":"Wang, Y., Su, M. A. & Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337\u2013348 (2011).","journal-title":"Immunity"},{"key":"1190_CR52","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.4049\/jimmunol.181.12.8391","volume":"181","author":"T Yamazaki","year":"2008","unstructured":"Yamazaki, T. et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181, 8391\u20138401 (2008).","journal-title":"J. Immunol."},{"key":"1190_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature07674","volume":"458","author":"Y Zheng","year":"2009","unstructured":"Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351\u2013356 (2009).","journal-title":"Nature"},{"key":"1190_CR54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.immuni.2012.05.031","volume":"37","author":"MA Koch","year":"2012","unstructured":"Koch, M. A. et al. T-bet+ Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor \u03b22. Immunity 37, 501\u2013510 (2012).","journal-title":"Immunity"},{"key":"1190_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"AG Levine","year":"2017","unstructured":"Levine, A. G. et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421\u2013425 (2017).","journal-title":"Nature"},{"key":"1190_CR56","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ni.1774","volume":"10","author":"X Zhou","year":"2009","unstructured":"Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000\u20131007 (2009).","journal-title":"Nat. Immunol."},{"key":"1190_CR57","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1073\/pnas.0811556106","volume":"106","author":"N Komatsu","year":"2009","unstructured":"Komatsu, N. et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl Acad. Sci. USA 106, 1903\u20131908 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR58","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.immuni.2013.10.016","volume":"39","author":"SL Bailey-Bucktrout","year":"2013","unstructured":"Bailey-Bucktrout, S. L. et al. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39, 949\u2013962 (2013).","journal-title":"Immunity"},{"key":"1190_CR59","doi-asserted-by":"publisher","first-page":"eabe4723","DOI":"10.1126\/sciimmunol.abe4723","volume":"6","author":"S Junius","year":"2021","unstructured":"Junius, S. et al. Unstable regulatory T cells, enriched for naive and Nrp1neg cells, are purged after fate challenge. Sci. Immunol. 6, eabe4723 (2021).","journal-title":"Sci. Immunol."},{"key":"1190_CR60","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","volume":"36","author":"T Miyao","year":"2012","unstructured":"Miyao, T. et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262\u2013275 (2012).","journal-title":"Immunity"},{"key":"1190_CR61","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nm.4147","volume":"22","author":"AH Massoud","year":"2016","unstructured":"Massoud, A. H. et al. An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells. Nat. Med. 22, 1013\u20131022 (2016).","journal-title":"Nat. Med."},{"key":"1190_CR62","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/eji.201747244","volume":"48","author":"P Tabares","year":"2018","unstructured":"Tabares, P. et al. Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral blood. Eur. J. Immunol. 48, 366\u2013379 (2018).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR63","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41590-023-01589-9","volume":"24","author":"A Freuchet","year":"2023","unstructured":"Freuchet, A. et al. Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells. Nat. Immunol. 24, 1748\u20131761 (2023).","journal-title":"Nat. Immunol."},{"key":"1190_CR64","doi-asserted-by":"publisher","first-page":"eadg6822","DOI":"10.1126\/scitranslmed.adg6822","volume":"15","author":"S Borna","year":"2023","unstructured":"Borna, S. et al. Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations. Sci. Transl. Med. 15, eadg6822 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1190_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida, T. S., Cheru, N. T. & Hafler, D. A. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat. Rev. Immunol. 24, 503\u2013517 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1190_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cell.2012.06.053","volume":"151","author":"RM Samstein","year":"2012","unstructured":"Samstein, R. M. et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153\u2013166 (2012).","journal-title":"Cell"},{"key":"1190_CR67","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41590-021-00910-8","volume":"22","author":"D Zemmour","year":"2021","unstructured":"Zemmour, D. et al. Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations. Nat. Immunol. 22, 607\u2013619 (2021).","journal-title":"Nat. Immunol."},{"key":"1190_CR68","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature08750","volume":"463","author":"Y Zheng","year":"2010","unstructured":"Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808\u2013812 (2010).","journal-title":"Nature"},{"key":"1190_CR69","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2014.07.031","volume":"158","author":"Y Feng","year":"2014","unstructured":"Feng, Y. et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell 158, 749\u2013763 (2014).","journal-title":"Cell"},{"key":"1190_CR70","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nature16141","volume":"528","author":"Y Feng","year":"2015","unstructured":"Feng, Y. et al. A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature 528, 132\u2013136 (2015).","journal-title":"Nature"},{"key":"1190_CR71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ni.3646","volume":"18","author":"Y Kitagawa","year":"2017","unstructured":"Kitagawa, Y. et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat. Immunol. 18, 173\u2013183 (2017).","journal-title":"Nat. Immunol."},{"key":"1190_CR72","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2021.04.005","volume":"54","author":"R Kawakami","year":"2021","unstructured":"Kawakami, R. et al. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Immunity 54, 947\u2013961.e8 (2021).","journal-title":"Immunity"},{"key":"1190_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nri2474","volume":"9","author":"J Huehn","year":"2009","unstructured":"Huehn, J., Polansky, J. K. & Hamann, A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9, 83\u201389 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"1190_CR74","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.1191996","volume":"329","author":"YP Rubtsov","year":"2010","unstructured":"Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667\u20131671 (2010).","journal-title":"Science"},{"key":"1190_CR75","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/eji.200838105","volume":"38","author":"JK Polansky","year":"2008","unstructured":"Polansky, J. K. et al. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38, 1654\u20131663 (2008).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR76","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","volume":"37","author":"N Ohkura","year":"2012","unstructured":"Ohkura, N. et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785\u2013799 (2012).","journal-title":"Immunity"},{"key":"1190_CR77","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1084\/jem.20050419","volume":"201","author":"B Sawitzki","year":"2005","unstructured":"Sawitzki, B. et al. IFN-\u03b3 production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201, 1925\u20131935 (2005).","journal-title":"J. Exp. Med."},{"key":"1190_CR78","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nm.2389","volume":"17","author":"M Dominguez-Villar","year":"2011","unstructured":"Dominguez-Villar, M., Baecher-Allan, C. M. & Hafler, D. A. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673\u2013675 (2011).","journal-title":"Nat. Med."},{"key":"1190_CR79","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","volume":"112","author":"HJ Koenen","year":"2008","unstructured":"Koenen, H. J. et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340\u20132352 (2008).","journal-title":"Blood"},{"key":"1190_CR80","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1073\/pnas.0900408106","volume":"106","author":"KS Voo","year":"2009","unstructured":"Voo, K. S. et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl Acad. Sci. USA 106, 4793\u20134798 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR81","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4049\/jimmunol.176.5.2857","volume":"176","author":"M Feuerer","year":"2006","unstructured":"Feuerer, M., Eulenburg, K., Loddenkemper, C., Hamann, A. & Huehn, J. Self-limitation of Th1-mediated inflammation by IFN-\u03b3. J. Immunol. 176, 2857\u20132863 (2006).","journal-title":"J. Immunol."},{"key":"1190_CR82","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.1736","volume":"10","author":"W O\u2019Connor Jr","year":"2009","unstructured":"O\u2019Connor, W. Jr et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603\u2013609 (2009).","journal-title":"Nat. Immunol."},{"key":"1190_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I Raphael","year":"2015","unstructured":"Raphael, I., Nalawade, S., Eagar, T. N. & Forsthuber, T. G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74, 5\u201317 (2015).","journal-title":"Cytokine"},{"key":"1190_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03147-6","volume":"9","author":"M Tsukasaki","year":"2018","unstructured":"Tsukasaki, M. et al. Host defense against oral microbiota by bone-damaging T cells. Nat. Commun. 9, 701 (2018).","journal-title":"Nat. Commun."},{"key":"1190_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-021-00590-6","volume":"17","author":"PA Nigrovic","year":"2021","unstructured":"Nigrovic, P. A. et al. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat. Rev. Rheumatol. 17, 257\u2013269 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1190_CR86","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ng.2504","volume":"45","author":"G Trynka","year":"2013","unstructured":"Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124\u2013130 (2013).","journal-title":"Nat. Genet."},{"key":"1190_CR87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337\u2013343 (2015).","journal-title":"Nature"},{"key":"1190_CR88","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.immuni.2020.04.006","volume":"52","author":"N Ohkura","year":"2020","unstructured":"Ohkura, N. et al. Regulatory T cell-specific epigenomic region variants are a key determinant of susceptibility to common autoimmune diseases. Immunity 52, 1119\u20131132.e4 (2020).","journal-title":"Immunity"},{"key":"1190_CR89","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07571","volume":"4","author":"A Arvey","year":"2015","unstructured":"Arvey, A. et al. Genetic and epigenetic variation in the lineage specification of regulatory T cells. eLife 4, e07571 (2015).","journal-title":"eLife"},{"key":"1190_CR90","doi-asserted-by":"publisher","first-page":"100117","DOI":"10.1016\/j.xgen.2022.100117","volume":"106","author":"L Bossini-Castillo","year":"2022","unstructured":"Bossini-Castillo, L. et al. Immune disease variants modulate gene expression in regulatory CD4+ T cells. Cell Genom. 2, 100117 (2022).","journal-title":"Cell Genom"},{"key":"1190_CR91","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381 (2014).","journal-title":"Nature"},{"key":"1190_CR92","doi-asserted-by":"crossref","unstructured":"Rodolfi, S., Davidson, C. & Vecellio, M. Regulatory T cells in spondyloarthropathies: genetic evidence, functional role, and therapeutic possibilities. Front. Immunol. 14, 1303640 (2023).","DOI":"10.3389\/fimmu.2023.1303640"},{"key":"1190_CR93","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","volume":"19","author":"JH Park","year":"2020","unstructured":"Park, J. H. et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review. Autoimmun. Rev. 19, 102526 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1190_CR94","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2023.11.021","volume":"153","author":"R Bacchetta","year":"2024","unstructured":"Bacchetta, R. & Roncarolo, M. G. IPEX syndrome from diagnosis to cure, learning along the way. J. Allergy Clin. Immunol. 153, 595\u2013605 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1190_CR95","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/art.20499","volume":"50","author":"JM van Amelsfort","year":"2004","unstructured":"van Amelsfort, J. M., Jacobs, K. M., Bijlsma, J. W., Lafeber, F. P. & Taams, L. S. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50, 2775\u20132785 (2004).","journal-title":"Arthritis Rheum."},{"key":"1190_CR96","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","volume":"253","author":"GM Han","year":"2008","unstructured":"Han, G. M., O\u2019Neil-Andersen, N. J., Zurier, R. B. & Lawrence, D. A. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol. 253, 92\u2013101 (2008).","journal-title":"Cell Immunol."},{"key":"1190_CR97","doi-asserted-by":"publisher","first-page":"R335","DOI":"10.1186\/ar1192","volume":"6","author":"D Cao","year":"2004","unstructured":"Cao, D., van Vollenhoven, R., Klareskog, L., Trollmo, C. & Malmstrom, V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6, R335\u2013R346 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"1190_CR98","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3899\/jrheum.110283","volume":"38","author":"SY Kawashiri","year":"2011","unstructured":"Kawashiri, S. Y. et al. CD4+CD25highCD127low\/\u2212 Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J. Rheumatol. 38, 2517\u20132521 (2011).","journal-title":"J. Rheumatol."},{"key":"1190_CR99","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","volume":"32","author":"Q Niu","year":"2012","unstructured":"Niu, Q., Cai, B., Huang, Z. C., Shi, Y. Y. & Wang, L. L. Disturbed Th17\/Treg balance in patients with rheumatoid arthritis. Rheumatol. Int. 32, 2731\u20132736 (2012).","journal-title":"Rheumatol. Int."},{"key":"1190_CR100","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.34477","volume":"64","author":"M Samson","year":"2012","unstructured":"Samson, M. et al. Brief report: inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum. 64, 2499\u20132503 (2012).","journal-title":"Arthritis Rheum."},{"key":"1190_CR101","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","volume":"140","author":"M Mottonen","year":"2005","unstructured":"Mottonen, M. et al. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140, 360\u2013367 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"1190_CR102","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-3083.2005.01656.x","volume":"62","author":"MF Liu","year":"2005","unstructured":"Liu, M. F., Wang, C. R., Fung, L. L., Lin, L. H. & Tsai, C. N. The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand. J. Immunol. 62, 312\u2013317 (2005).","journal-title":"Scand. J. Immunol."},{"key":"1190_CR103","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat. Med. 19, 322\u2013328 (2013).","journal-title":"Nat. Med."},{"key":"1190_CR104","doi-asserted-by":"publisher","first-page":"108425","DOI":"10.1016\/j.clim.2020.108425","volume":"215","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Jarjour, W., Olsen, N. & Zheng, S. G. Traitor or warrior-Treg cells sneaking into the lesions of psoriatic arthritis. Clin. Immunol. 215, 108425 (2020).","journal-title":"Clin. Immunol."},{"key":"1190_CR105","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","volume":"172","author":"IM de Kleer","year":"2004","unstructured":"de Kleer, I. M. et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172, 6435\u20136443 (2004).","journal-title":"J. Immunol."},{"key":"1190_CR106","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3899\/jrheum.090066","volume":"36","author":"B Olivito","year":"2009","unstructured":"Olivito, B. et al. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J. Rheumatol. 36, 2017\u20132024 (2009).","journal-title":"J. Rheumatol."},{"key":"1190_CR107","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00296-010-1728-3","volume":"32","author":"A Stelmaszczyk-Emmel","year":"2012","unstructured":"Stelmaszczyk-Emmel, A., Jackowska, T., Rutkowska-Sak, L., Marusak-Banacka, M. & Wasik, M. Identification, frequency, activation and function of CD4+ CD25highFoxP3+ regulatory T cells in children with juvenile idiopathic arthritis. Rheumatol. Int. 32, 1147\u20131154 (2012).","journal-title":"Rheumatol. Int."},{"key":"1190_CR108","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12969-022-00680-z","volume":"20","author":"MT Holzer","year":"2022","unstructured":"Holzer, M. T. et al. Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients. Pediatr. Rheumatol. Online J. 20, 26 (2022).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"1190_CR109","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/cei.12668","volume":"182","author":"M Muller","year":"2015","unstructured":"Muller, M., Herrath, J. & Malmstrom, V. IL-1R1 is expressed on both Helios+ and Helios\u2212 FoxP3+ CD4+ T cells in the rheumatic joint. Clin. Exp. Immunol. 182, 90\u2013100 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"1190_CR110","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.33594\/000000080","volume":"52","author":"M Yang","year":"2019","unstructured":"Yang, M. et al. Helios but not CD226, TIGIT and Foxp3 is a potential marker for CD4+ Treg cells in patients with rheumatoid arthritis. Cell Physiol. Biochem. 52, 1178\u20131192 (2019).","journal-title":"Cell Physiol. Biochem."},{"key":"1190_CR111","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3390\/cells11142171","volume":"11","author":"M Dittrich-Salamon","year":"2022","unstructured":"Dittrich-Salamon, M. et al. Regulatory T cells from patients with rheumatoid arthritis are characterized by reduced expression of Ikaros zinc finger transcription factors. Cells 11, 2171 (2022).","journal-title":"Cells"},{"key":"1190_CR112","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/03009740701482800","volume":"36","author":"Z Jiao","year":"2007","unstructured":"Jiao, Z. et al. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand. J. Rheumatol. 36, 428\u2013433 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"1190_CR113","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s10067-015-3002-2","volume":"34","author":"U Fiocco","year":"2015","unstructured":"Fiocco, U. et al. Transcriptional network profile on synovial fluid T cells in psoriatic arthritis. Clin. Rheumatol. 34, 1571\u20131580 (2015).","journal-title":"Clin. Rheumatol."},{"key":"1190_CR114","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3899\/jrheum.110377","volume":"38","author":"H Appel","year":"2011","unstructured":"Appel, H. et al. Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis. J. Rheumatol. 38, 2445\u20132451 (2011).","journal-title":"J. Rheumatol."},{"key":"1190_CR115","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79016","volume":"12","author":"G Mijnheer","year":"2023","unstructured":"Mijnheer, G. et al. Compartmentalization and persistence of dominant (regulatory) T cell clones indicates antigen skewing in juvenile idiopathic arthritis. eLife 12, e79016 (2023).","journal-title":"eLife"},{"key":"1190_CR116","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149185","volume":"6","author":"AM Jule","year":"2021","unstructured":"Jule, A. M. et al. Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. JCI insight 6, e149185 (2021).","journal-title":"JCI insight"},{"key":"1190_CR117","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/art.22272","volume":"56","author":"LT Nguyen","year":"2007","unstructured":"Nguyen, L. T., Jacobs, J., Mathis, D. & Benoist, C. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56, 509\u2013520 (2007).","journal-title":"Arthritis Rheum."},{"key":"1190_CR118","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/immu.200390024","volume":"33","author":"D Cao","year":"2003","unstructured":"Cao, D. et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33, 215\u2013223 (2003).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR119","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","volume":"16","author":"B Moradi","year":"2014","unstructured":"Moradi, B. et al. CD4+CD25+\/highCD127low\/\u2212 regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints \u2014 analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res. Ther. 16, R97 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"1190_CR120","doi-asserted-by":"crossref","unstructured":"Attrill, M. H. et al. The immune landscape of the inflamed joint defined by spectral flow cytometry. Clin. Exp. Immunol. 218, 221\u2013241 (2024).","DOI":"10.1101\/2023.11.30.569010"},{"key":"1190_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22975-7","volume":"12","author":"G Mijnheer","year":"2021","unstructured":"Mijnheer, G. et al. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation. Nat. Commun. 12, 2710 (2021).","journal-title":"Nat. Commun."},{"key":"1190_CR122","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12026-023-09444-7","volume":"72","author":"V Kommoju","year":"2023","unstructured":"Kommoju, V. et al. Conventional Tregs in treatment-naive rheumatoid arthritis are deficient in suppressive function with an increase in percentage of CXCR3 and CCR6 expressing Tregs. Immunol. Res. 72, 396\u2013408 (2023).","journal-title":"Immunol. Res."},{"key":"1190_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1420","volume":"11","author":"L Lutter","year":"2022","unstructured":"Lutter, L. et al. Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint. Clin. Transl. Immunol. 11, e1420 (2022).","journal-title":"Clin. Transl. Immunol."},{"key":"1190_CR124","doi-asserted-by":"publisher","first-page":"1068399","DOI":"10.3389\/fimmu.2022.1068399","volume":"13","author":"AM Jule","year":"2022","unstructured":"Jule, A. M. et al. Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. Front. Immunol. 13, 1068399 (2022).","journal-title":"Front. Immunol."},{"key":"1190_CR125","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/eji.202048797","volume":"51","author":"P Maschmeyer","year":"2021","unstructured":"Maschmeyer, P. et al. Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T\u00a0lymphocytes regulate juvenile idiopathic arthritis in situ. Eur. J. Immunol. 51, 915\u2013929 (2021).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR126","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s42003-021-02931-3","volume":"4","author":"D Simone","year":"2021","unstructured":"Simone, D. et al. Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates. Commun. Biol. 4, 1395 (2021).","journal-title":"Commun. Biol."},{"key":"1190_CR127","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","volume":"121","author":"AM Pesenacker","year":"2013","unstructured":"Pesenacker, A. M. et al. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 121, 2647\u20132658 (2013).","journal-title":"Blood"},{"key":"1190_CR128","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110\u2013114 (2017).","journal-title":"Nature"},{"key":"1190_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46457-8","volume":"15","author":"T Kim","year":"2024","unstructured":"Kim, T. et al. Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development. Nat. Commun. 15, 2150 (2024).","journal-title":"Nat. Commun."},{"key":"1190_CR130","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","volume":"108","author":"X Valencia","year":"2006","unstructured":"Valencia, X. et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108, 253\u2013261 (2006).","journal-title":"Blood"},{"key":"1190_CR131","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/rheumatology\/keq237","volume":"49","author":"JA van Roon","year":"2010","unstructured":"van Roon, J. A., Hartgring, S. A., van der Wurff-Jacobs, K. M., Bijlsma, J. W. & Lafeber, F. P. Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients. Rheumatology 49, 2084\u20132089 (2010).","journal-title":"Rheumatology"},{"key":"1190_CR132","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy. J. Exp. Med. 200, 277\u2013285 (2004).","journal-title":"J. Exp. Med."},{"key":"1190_CR133","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja, F., Jury, E. C., Mauri, C. & Ehrenstein, M. R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 105, 19396\u201319401 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR134","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1126\/science.1186068","volume":"328","author":"A Zanin-Zhorov","year":"2010","unstructured":"Zanin-Zhorov, A. et al. Protein kinase C-\u03b8 mediates negative feedback on regulatory T cell function. Science 328, 372\u2013376 (2010).","journal-title":"Science"},{"key":"1190_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76168-1","volume":"10","author":"K Kanjana","year":"2020","unstructured":"Kanjana, K., Chevaisrakul, P., Matangkasombut, P., Paisooksantivatana, K. & Lumjiaktase, P. Inhibitory activity of FOXP3+ regulatory T cells reveals high specificity for displaying immune tolerance in remission state rheumatoid arthritis. Sci. Rep. 10, 19789 (2020).","journal-title":"Sci. Rep."},{"key":"1190_CR136","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","volume":"107","author":"I de Kleer","year":"2006","unstructured":"de Kleer, I. et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 107, 1696\u20131702 (2006).","journal-title":"Blood"},{"key":"1190_CR137","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-015-0526-4","volume":"17","author":"J Kikuchi","year":"2015","unstructured":"Kikuchi, J. et al. Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response. Arthritis Res. Ther. 17, 10 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"1190_CR138","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/art.11063","volume":"48","author":"ME Morgan","year":"2003","unstructured":"Morgan, M. E. et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48, 1452\u20131460 (2003).","journal-title":"Arthritis Rheum."},{"key":"1190_CR139","doi-asserted-by":"publisher","first-page":"R291","DOI":"10.1186\/ar1484","volume":"7","author":"O Frey","year":"2005","unstructured":"Frey, O. et al. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res. Ther. 7, R291\u2013R301 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"1190_CR140","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/art.21195","volume":"52","author":"ME Morgan","year":"2005","unstructured":"Morgan, M. E. et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52, 2212\u20132221 (2005).","journal-title":"Arthritis Rheum."},{"key":"1190_CR141","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1002\/art.22846","volume":"56","author":"J Ohata","year":"2007","unstructured":"Ohata, J. et al. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts. Arthritis Rheum. 56, 2947\u20132956 (2007).","journal-title":"Arthritis Rheum."},{"key":"1190_CR142","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.4049\/jimmunol.179.6.3412","volume":"179","author":"N Fazilleau","year":"2007","unstructured":"Fazilleau, N., Bachelez, H., Gougeon, M. L. & Viguier, M. Cutting edge: size and diversity of CD4+CD25high Foxp3+ regulatory T cell repertoire in humans: evidence for similarities and partial overlapping with CD4+CD25\u2212 T cells. J. Immunol. 179, 3412\u20133416 (2007).","journal-title":"J. Immunol."},{"key":"1190_CR143","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/eji.201141986","volume":"41","author":"L Fohse","year":"2011","unstructured":"Fohse, L. et al. High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur. J. Immunol. 41, 3101\u20133113 (2011).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR144","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.4049\/jimmunol.1601966","volume":"198","author":"A Yu","year":"2017","unstructured":"Yu, A. et al. The lower limit of regulatory CD4+ Foxp3+ TCR\u03b2 repertoire diversity required to control autoimmunity. J. Immunol. 198, 3127\u20133135 (2017).","journal-title":"J. Immunol."},{"key":"1190_CR145","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/art.39606","volume":"68","author":"LA Henderson","year":"2016","unstructured":"Henderson, L. A. et al. Next-generation sequencing reveals restriction and clonotypic expansion of Treg cells in juvenile idiopathic arthritis. Arthritis Rheumatol. 68, 1758\u20131768 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1190_CR146","doi-asserted-by":"publisher","first-page":"8320","DOI":"10.1073\/pnas.0808493106","volume":"106","author":"C Ferreira","year":"2009","unstructured":"Ferreira, C. et al. Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells. Proc. Natl Acad. Sci. USA 106, 8320\u20138325 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR147","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/blood-2008-12-192120","volume":"114","author":"A Le Campion","year":"2009","unstructured":"Le Campion, A. et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood 114, 1784\u20131793 (2009).","journal-title":"Blood"},{"key":"1190_CR148","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.4049\/jimmunol.1000848","volume":"185","author":"S Tanaka","year":"2010","unstructured":"Tanaka, S. et al. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J. Immunol. 185, 2295\u20132305 (2010).","journal-title":"J. Immunol."},{"key":"1190_CR149","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1073\/pnas.1110120109","volume":"109","author":"A Zanin-Zhorov","year":"2012","unstructured":"Zanin-Zhorov, A. et al. Scaffold protein disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function. Proc. Natl Acad. Sci. USA 109, 1625\u20131630 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR150","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.1078231","volume":"299","author":"C Pasare","year":"2003","unstructured":"Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033\u20131036 (2003).","journal-title":"Science"},{"key":"1190_CR151","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4049\/jimmunol.178.1.271","volume":"178","author":"S Wan","year":"2007","unstructured":"Wan, S., Xia, C. & Morel, L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J. Immunol. 178, 271\u2013279 (2007).","journal-title":"J. Immunol."},{"key":"1190_CR152","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","volume":"31","author":"G Oldenhove","year":"2009","unstructured":"Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772\u2013786 (2009).","journal-title":"Immunity"},{"key":"1190_CR153","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E. V. et al. Control of TH17\/Treg balance by hypoxia-inducible factor 1. Cell 146, 772\u2013784 (2011).","journal-title":"Cell"},{"key":"1190_CR154","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3389\/fimmu.2020.01668","volume":"11","author":"X Guo","year":"2020","unstructured":"Guo, X. & Chen, G. Hypoxia-inducible factor is critical for pathogenesis and regulation of immune cell functions in rheumatoid arthritis. Front. Immunol. 11, 1668 (2020).","journal-title":"Front. Immunol."},{"key":"1190_CR155","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00262-020-02842-y","volume":"70","author":"V Sasidharan Nair","year":"2021","unstructured":"Sasidharan Nair, V., Saleh, R., Toor, S. M., Cyprian, F. S. & Elkord, E. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment. Cancer Immunol. Immunother. 70, 2103\u20132121 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"1190_CR156","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada, T. et al. PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc. Natl Acad. Sci. USA 116, 9999\u201310008 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR157","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182232","volume":"218","author":"CL Tan","year":"2021","unstructured":"Tan, C. L. et al. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance. J. Exp. Med. 218, e20182232 (2021).","journal-title":"J. Exp. Med."},{"key":"1190_CR158","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/annrheumdis-2021-221866","volume":"81","author":"R Grieshaber-Bouyer","year":"2022","unstructured":"Grieshaber-Bouyer, R. et al. Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. Ann. Rheum. Dis. 81, 805\u2013814 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1190_CR159","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/art.30503","volume":"63","author":"S Haufe","year":"2011","unstructured":"Haufe, S. et al. Impaired suppression of synovial fluid CD4+CD25\u2212 T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum. 63, 3153\u20133162 (2011).","journal-title":"Arthritis Rheum."},{"key":"1190_CR160","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","volume":"118","author":"EJ Wehrens","year":"2011","unstructured":"Wehrens, E. J. et al. Functional human regulatory T cells fail to control autoimmune inflammation due to PKB\/c-akt hyperactivation in effector cells. Blood 118, 3538\u20133548 (2011).","journal-title":"Blood"},{"key":"1190_CR161","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.immuni.2013.10.023","volume":"40","author":"D Schenten","year":"2014","unstructured":"Schenten, D. et al. Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells. Immunity 40, 78\u201390 (2014).","journal-title":"Immunity"},{"key":"1190_CR162","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125278","volume":"4","author":"MH Chang","year":"2019","unstructured":"Chang, M. H. & Nigrovic, P. A. Antibody-dependent and -independent mechanisms of inflammatory arthritis. JCI Insight 4, e125278 (2019).","journal-title":"JCI Insight"},{"key":"1190_CR163","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.smim.2013.10.009","volume":"25","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld, M. & Hafler, D. A. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin. Immunol. 25, 78\u2013312 (2013).","journal-title":"Semin. Immunol."},{"key":"1190_CR164","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"1190_CR165","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen, W. et al. Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3. J. Exp. Med. 198, 1875\u20131886 (2003).","journal-title":"J. Exp. Med."},{"key":"1190_CR166","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"1190_CR167","doi-asserted-by":"publisher","first-page":"6309219","DOI":"10.1155\/2016\/6309219","volume":"2016","author":"ML Diller","year":"2016","unstructured":"Diller, M. L., Kudchadkar, R. R., Delman, K. A., Lawson, D. H. & Ford, M. L. Balancing inflammation: the link between Th17 and regulatory T cells. Mediators Inflamm. 2016, 6309219 (2016).","journal-title":"Mediators Inflamm."},{"key":"1190_CR168","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1145697","volume":"317","author":"D Mucida","year":"2007","unstructured":"Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256\u2013260 (2007).","journal-title":"Science"},{"key":"1190_CR169","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature06878","volume":"453","author":"L Zhou","year":"2008","unstructured":"Zhou, L. et al. TGF-\u03b2-induced Foxp3 inhibits TH17 cell differentiation by antagonizing ROR\u03b3t function. Nature 453, 236\u2013240 (2008).","journal-title":"Nature"},{"key":"1190_CR170","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221\u2013225 (2015).","journal-title":"Nature"},{"key":"1190_CR171","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala, K. et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58, 875\u2013887 (2008).","journal-title":"Arthritis Rheum."},{"key":"1190_CR172","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00296-010-1710-0","volume":"32","author":"W Wang","year":"2012","unstructured":"Wang, W. et al. The Th17\/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 32, 887\u2013893 (2012).","journal-title":"Rheumatol. Int."},{"key":"1190_CR173","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/JLB.4RU0619-197R","volume":"106","author":"P Yang","year":"2019","unstructured":"Yang, P. et al. Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J. Leukoc. Biol. 106, 1233\u20131240 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"1190_CR174","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/annrheumdis-2013-204228","volume":"74","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Ann. Rheum. Dis. 74, 1293\u20131301 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1190_CR175","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fimmu.2017.00103","volume":"8","author":"CL Duurland","year":"2017","unstructured":"Duurland, C. L., Brown, C. C., O\u2019Shaughnessy, R. F. & Wedderburn, L. R. CD161+ Tconv and CD161+ Treg share a transcriptional and functional phenotype despite limited overlap in TCR\u03b2 repertoire. Front. Immunol. 8, 103 (2017).","journal-title":"Front. Immunol."},{"key":"1190_CR176","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132508","volume":"5","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. et al. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI insight 5, e132508 (2020).","journal-title":"JCI insight"},{"key":"1190_CR177","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","volume":"186","author":"SA McClymont","year":"2011","unstructured":"McClymont, S. A. et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918\u20133926 (2011).","journal-title":"J. Immunol."},{"key":"1190_CR178","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein, B. N. & Aune, T. M. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat. Rev. Rheumatol. 16, 145\u2013154 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1190_CR179","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.39031","volume":"67","author":"AP Cribbs","year":"2015","unstructured":"Cribbs, A. P. et al. Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis. Arthritis Rheumatol. 67, 1182\u20131192 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1190_CR180","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164778","volume":"8","author":"K Suga","year":"2023","unstructured":"Suga, K. et al. TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis. JCI insight 8, e164778 (2023).","journal-title":"JCI insight"},{"key":"1190_CR181","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.1424792112","volume":"112","author":"RS Peres","year":"2015","unstructured":"Peres, R. S. et al. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 112, 2509\u20132514 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR182","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/1756-185X.13333","volume":"21","author":"V Gupta","year":"2018","unstructured":"Gupta, V., Katiyar, S., Singh, A., Misra, R. & Aggarwal, A. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis. Int. J. Rheum. Dis. 21, 1548\u20131556 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"1190_CR183","doi-asserted-by":"crossref","unstructured":"Brown, P. M. et al. Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis. RMD Open 10, e003858 (2024).","DOI":"10.1136\/rmdopen-2023-003858"},{"key":"1190_CR184","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216576","volume":"80","author":"A Meyer","year":"2021","unstructured":"Meyer, A. et al. Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors. Ann. Rheum. Dis. 80, e196 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1190_CR185","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/rheumatology\/kev101","volume":"54","author":"M Bulatovic Calasan","year":"2015","unstructured":"Bulatovic Calasan, M. et al. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis. Rheumatology 54, 1724\u20131734 (2015).","journal-title":"Rheumatology"},{"key":"1190_CR186","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.20061531","volume":"204","author":"S Nadkarni","year":"2007","unstructured":"Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2. J. Exp. Med. 204, 33\u201339 (2007).","journal-title":"J. Exp. Med."},{"key":"1190_CR187","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.4049\/jimmunol.1003372","volume":"186","author":"J Biton","year":"2011","unstructured":"Biton, J. et al. Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J. Immunol. 186, 3899\u20133910 (2011).","journal-title":"J. Immunol."},{"key":"1190_CR188","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/art.39418","volume":"68","author":"A Petrelli","year":"2016","unstructured":"Petrelli, A. et al. Self-sustained resistance to suppression of CD8+ Teff cells at the site of autoimmune inflammation can be reversed by tumor necrosis factor and interferon-\u03b3 blockade. Arthritis Rheumatol. 68, 229\u2013236 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1190_CR189","doi-asserted-by":"publisher","first-page":"13051","DOI":"10.1073\/pnas.1807499115","volume":"115","author":"KN Atretkhany","year":"2018","unstructured":"Atretkhany, K. N. et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc. Natl Acad. Sci. USA 115, 13051\u201313056 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR190","doi-asserted-by":"crossref","unstructured":"Ronin, E. et al. Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells. Proc. Natl Acad. Sci. USA 118, e2014043118 (2021).","DOI":"10.1073\/pnas.2014043118"},{"key":"1190_CR191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156311","volume":"11","author":"X He","year":"2016","unstructured":"He, X. et al. A TNFR2-agonist facilitates high purity expansion of human low purity Treg cells. PLoS ONE 11, e0156311 (2016).","journal-title":"PLoS ONE"},{"key":"1190_CR192","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fimmu.2018.00573","volume":"9","author":"PCM Urbano","year":"2018","unstructured":"Urbano, P. C. M., Koenen, H., Joosten, I. & He, X. An autocrine TNF\u03b1-tumor necrosis factor receptor 2 loop promotes epigenetic effects inducing human Treg stability in vitro. Front. Immunol. 9, 573 (2018).","journal-title":"Front. Immunol."},{"key":"1190_CR193","doi-asserted-by":"publisher","first-page":"783282","DOI":"10.3389\/fimmu.2021.783282","volume":"12","author":"N Skartsis","year":"2021","unstructured":"Skartsis, N. et al. IL-6 and TNF\u03b1 drive extensive proliferation of human Tregs without compromising their lineage stability or function. Front. Immunol. 12, 783282 (2021).","journal-title":"Front. Immunol."},{"key":"1190_CR194","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1002\/art.34565","volume":"64","author":"JL McGovern","year":"2012","unstructured":"McGovern, J. L. et al. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum. 64, 3129\u20133138 (2012).","journal-title":"Arthritis Rheum."},{"key":"1190_CR195","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.20151255","volume":"213","author":"DX Nguyen","year":"2016","unstructured":"Nguyen, D. X. & Ehrenstein, M. R. Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis. J. Exp. Med. 213, 1241\u20131253 (2016).","journal-title":"J. Exp. Med."},{"key":"1190_CR196","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jaci.2018.04.026","volume":"142","author":"DX Nguyen","year":"2018","unstructured":"Nguyen, D. X. et al. Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis. J. Allergy Clin. Immunol. 142, 978\u2013980.e9 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1190_CR197","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","volume":"179","author":"X Chen","year":"2007","unstructured":"Chen, X., Baumel, M., Mannel, D. N., Howard, O. M. & Oppenheim, J. J. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179, 154\u2013161 (2007).","journal-title":"J. Immunol."},{"key":"1190_CR198","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","volume":"114","author":"X Chen","year":"2009","unstructured":"Chen, X. et al. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 114, 891\u2013900 (2009).","journal-title":"Blood"},{"key":"1190_CR199","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/art.38246","volume":"66","author":"A Thiolat","year":"2014","unstructured":"Thiolat, A. et al. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol. 66, 273\u2013283 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1190_CR200","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4049\/jimmunol.1300387","volume":"192","author":"S Ikeda","year":"2014","unstructured":"Ikeda, S. et al. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-\u03b2-induced Foxp3 expression. J. Immunol. 192, 1449\u20131458 (2014).","journal-title":"J. Immunol."},{"key":"1190_CR201","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.4049\/jimmunol.1001536","volume":"185","author":"L Li","year":"2010","unstructured":"Li, L., Kim, J. & Boussiotis, V. A. IL-1\u03b2-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells. J. Immunol. 185, 4148\u20134153 (2010).","journal-title":"J. Immunol."},{"key":"1190_CR202","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","volume":"131","author":"F Deknuydt","year":"2009","unstructured":"Deknuydt, F., Bioley, G., Valmori, D. & Ayyoub, M. IL-1\u03b2 and IL-2 convert human Treg into TH17 cells. Clin. Immunol. 131, 298\u2013307 (2009).","journal-title":"Clin. Immunol."},{"key":"1190_CR203","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/rheumatology\/kes162","volume":"51","author":"E Omoyinmi","year":"2012","unstructured":"Omoyinmi, E. et al. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology 51, 1881\u20131886 (2012).","journal-title":"Rheumatology"},{"key":"1190_CR204","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic, P. A. et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 63, 545\u2013555 (2011).","journal-title":"Arthritis Rheum."},{"key":"1190_CR205","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B Salomon","year":"2000","unstructured":"Salomon, B. et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431\u2013440 (2000).","journal-title":"Immunity"},{"key":"1190_CR206","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","volume":"171","author":"Q Tang","year":"2003","unstructured":"Tang, Q. et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171, 3348\u20133352 (2003).","journal-title":"J. Immunol."},{"key":"1190_CR207","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni1160","volume":"6","author":"X Tai","year":"2005","unstructured":"Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152\u2013162 (2005).","journal-title":"Nat. Immunol."},{"key":"1190_CR208","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2009.07.006","volume":"34","author":"HJ Ko","year":"2010","unstructured":"Ko, H. J. et al. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population. J. Autoimmun. 34, 111\u2013120 (2010).","journal-title":"J. Autoimmun."},{"key":"1190_CR209","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","volume":"31","author":"C Alvarez-Quiroga","year":"2011","unstructured":"Alvarez-Quiroga, C. et al. CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J. Clin. Immunol. 31, 588\u2013595 (2011).","journal-title":"J. Clin. Immunol."},{"key":"1190_CR210","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/cei.12367","volume":"177","author":"A Picchianti Diamanti","year":"2014","unstructured":"Picchianti Diamanti, A. et al. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-\u03b1 agents. Clin. Exp. Immunol. 177, 630\u2013640 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"1190_CR211","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/rheumatology\/kev403","volume":"55","author":"M Bonelli","year":"2016","unstructured":"Bonelli, M. et al. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis. Rheumatology 55, 710\u2013720 (2016).","journal-title":"Rheumatology"},{"key":"1190_CR212","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2172-14-34","volume":"14","author":"J Pieper","year":"2013","unstructured":"Pieper, J. et al. CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients. BMC Immunol. 14, 34 (2013).","journal-title":"BMC Immunol."},{"key":"1190_CR213","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153682","volume":"11","author":"JD Goldstein","year":"2016","unstructured":"Goldstein, J. D. et al. Inhibition of the JAK\/STAT signaling pathway in regulatory T cells reveals a very dynamic regulation of Foxp3 expression. PLoS ONE 11, e0153682 (2016).","journal-title":"PLoS ONE"},{"key":"1190_CR214","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1111\/j.1600-6143.2010.03200.x","volume":"10","author":"VD Sewgobind","year":"2010","unstructured":"Sewgobind, V. D. et al. The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells. Am. J. Transpl. 10, 1785\u20131795 (2010).","journal-title":"Am. J. Transpl."},{"key":"1190_CR215","first-page":"4883","volume":"20","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice. Mol. Med. Rep. 20, 4883\u20134892 (2019).","journal-title":"Mol. Med. Rep."},{"key":"1190_CR216","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","volume":"6","author":"JD Fontenot","year":"2005","unstructured":"Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142\u20131151 (2005).","journal-title":"Nat. Immunol."},{"key":"1190_CR217","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","volume":"108","author":"E Zorn","year":"2006","unstructured":"Zorn, E. et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108, 1571\u20131579 (2006).","journal-title":"Blood"},{"key":"1190_CR218","doi-asserted-by":"publisher","first-page":"179ra143","DOI":"10.1126\/scitranslmed.3005265","volume":"5","author":"K Matsuoka","year":"2013","unstructured":"Matsuoka, K. et al. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci. Transl. Med. 5, 179ra143 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1190_CR219","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","volume":"58","author":"M Rosenzwajg","year":"2015","unstructured":"Rosenzwajg, M. et al. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. J. Autoimmun. 58, 48\u201358 (2015).","journal-title":"J. Autoimmun."},{"key":"1190_CR220","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","volume":"75","author":"C von Spee-Mayer","year":"2016","unstructured":"von Spee-Mayer, C. et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 75, 1407\u20131415 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1190_CR221","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","volume":"78","author":"M Rosenzwajg","year":"2019","unstructured":"Rosenzwajg, M. et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann. Rheum. Dis. 78, 209\u2013217 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1190_CR222","doi-asserted-by":"publisher","first-page":"204062232091601","DOI":"10.1177\/2040622320916014","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2. Ther. Adv. Chronic Dis. 11, 2040622320916014 (2020).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"1190_CR223","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41392-022-00887-2","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial. Signal. Transduct. Target. Ther. 7, 67 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1190_CR224","doi-asserted-by":"publisher","first-page":"947341","DOI":"10.3389\/fimmu.2022.947341","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: a randomized controlled trial. Front. Immunol. 13, 947341 (2022).","journal-title":"Front. Immunol."},{"key":"1190_CR225","doi-asserted-by":"publisher","first-page":"106734","DOI":"10.1016\/j.isci.2023.106734","volume":"26","author":"QQ Huang","year":"2023","unstructured":"Huang, Q. Q. et al. Mechanisms regulating the loss of Tregs in HUPO mice that develop spontaneous inflammatory arthritis. iScience 26, 106734 (2023).","journal-title":"iScience"},{"key":"1190_CR226","doi-asserted-by":"publisher","first-page":"622810","DOI":"10.3389\/fimmu.2020.622810","volume":"11","author":"N Pilat","year":"2020","unstructured":"Pilat, N. & Sprent, J. Treg therapies revisited: tolerance beyond deletion. Front. Immunol. 11, 622810 (2020).","journal-title":"Front. Immunol."},{"key":"1190_CR227","doi-asserted-by":"publisher","first-page":"648408","DOI":"10.3389\/fimmu.2021.648408","volume":"12","author":"H Grasshoff","year":"2021","unstructured":"Grasshoff, H. et al. Low-dose IL-2 therapy in autoimmune and rheumatic diseases. Front. Immunol. 12, 648408 (2021).","journal-title":"Front. Immunol."},{"key":"1190_CR228","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","volume":"105","author":"M Battaglia","year":"2005","unstructured":"Battaglia, M., Stabilini, A. & Roncarolo, M. G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105, 4743\u20134748 (2005).","journal-title":"Blood"},{"key":"1190_CR229","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","volume":"177","author":"M Battaglia","year":"2006","unstructured":"Battaglia, M. et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338\u20138347 (2006).","journal-title":"J. Immunol."},{"key":"1190_CR230","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4049\/jimmunol.178.1.320","volume":"178","author":"L Strauss","year":"2007","unstructured":"Strauss, L. et al. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J. Immunol. 178, 320\u2013329 (2007).","journal-title":"J. Immunol."},{"key":"1190_CR231","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","volume":"3","author":"KL Hippen","year":"2011","unstructured":"Hippen, K. L. et al. Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity. Sci. Transl. Med. 3, 83ra41 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1190_CR232","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074450","volume":"8","author":"N Prevel","year":"2013","unstructured":"Prevel, N., Allenbach, Y., Klatzmann, D., Salomon, B. & Benveniste, O. Beneficial role of rapamycin in experimental autoimmune myositis. PLoS ONE 8, e74450 (2013).","journal-title":"PLoS ONE"},{"key":"1190_CR233","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","volume":"705","author":"Z Li","year":"2019","unstructured":"Li, Z., Nie, L., Chen, L., Sun, Y. & Li, G. Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model. Neurosci. Lett. 705, 39\u201345 (2019).","journal-title":"Neurosci. Lett."},{"key":"1190_CR234","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167457","volume":"9","author":"P Baeten","year":"2024","unstructured":"Baeten, P. et al. Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells. JCI Insight 9, e167457 (2024).","journal-title":"JCI Insight"},{"key":"1190_CR235","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41590-019-0442-x","volume":"20","author":"LM Charbonnier","year":"2019","unstructured":"Charbonnier, L. M. et al. Functional reprogramming of regulatory T cells in the absence of Foxp3. Nat. Immunol. 20, 1208\u20131219 (2019).","journal-title":"Nat. Immunol."},{"key":"1190_CR236","first-page":"58","volume":"38","author":"HQ Niu","year":"2020","unstructured":"Niu, H. Q. et al. Sirolimus selectively increases circulating Treg cell numbers and restores the Th17\/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs. Clin. Exp. Rheumatol. 38, 58\u201366 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1190_CR237","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","volume":"391","author":"ZW Lai","year":"2018","unstructured":"Lai, Z. W. et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial. Lancet 391, 1186\u20131196 (2018).","journal-title":"Lancet"},{"key":"1190_CR238","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12865-019-0305-0","volume":"20","author":"C Zhao","year":"2019","unstructured":"Zhao, C. et al. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17\/Treg cells in refractory SLE patients. BMC Immunol. 20, 32 (2019).","journal-title":"BMC Immunol."},{"key":"1190_CR239","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","volume":"141","author":"F Barzaghi","year":"2018","unstructured":"Barzaghi, F. et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. J. Allergy Clin. Immunol. 141, 1036\u20131049.e5 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1190_CR240","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","volume":"145","author":"L Passerini","year":"2020","unstructured":"Passerini, L. et al. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients. J. Allergy Clin. Immunol. 145, 1262\u20131271.e13 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1190_CR241","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34480-6","volume":"13","author":"Z Huang","year":"2022","unstructured":"Huang, Z. et al. mTORC1 links pathology in experimental models of Still\u2019s disease and macrophage activation syndrome. Nat. Commun. 13, 6915 (2022).","journal-title":"Nat. Commun."},{"key":"1190_CR242","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8086","volume":"6","author":"QQ Huang","year":"2015","unstructured":"Huang, Q. Q. et al. CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis. Nat. Commun. 6, 7086 (2015).","journal-title":"Nat. Commun."},{"key":"1190_CR243","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/eji.202048795","volume":"51","author":"H Waldmann","year":"2021","unstructured":"Waldmann, H. Regulatory T cells and transplantation tolerance: emerging from the darkness? Eur. J. Immunol. 51, 1580\u20131591 (2021).","journal-title":"Eur. J. Immunol."},{"key":"1190_CR244","doi-asserted-by":"publisher","first-page":"1166135","DOI":"10.3389\/fimmu.2023.1166135","volume":"14","author":"JA Bluestone","year":"2023","unstructured":"Bluestone, J. A., McKenzie, B. S., Beilke, J. & Ramsdell, F. Opportunities for Treg cell therapy for the treatment of human disease. Front. Immunol. 14, 1166135 (2023).","journal-title":"Front. Immunol."},{"key":"1190_CR245","doi-asserted-by":"publisher","first-page":"eaay6422","DOI":"10.1126\/scitranslmed.aay6422","volume":"12","author":"Y Honaker","year":"2020","unstructured":"Honaker, Y. et al. Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function. Sci. Transl. Med. 12, eaay6422 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1190_CR246","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171844","volume":"9","author":"GI Uenishi","year":"2024","unstructured":"Uenishi, G. I. et al. GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes. JCI Insight 9, e171844 (2024).","journal-title":"JCI Insight"},{"key":"1190_CR247","doi-asserted-by":"publisher","first-page":"1267762","DOI":"10.3389\/fmolb.2023.1267762","volume":"10","author":"CJ Requejo Cier","year":"2023","unstructured":"Requejo Cier, C. J., Valentini, N. & Lamarche, C. Unlocking the potential of Tregs: innovations in CAR technology. Front. Mol. Biosci. 10, 1267762 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"1190_CR248","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/rheumatology\/keac382","volume":"62","author":"K Furuyama","year":"2022","unstructured":"Furuyama, K. et al. Effecter Th17-like regulatory T cells associate with the pathogenesis of rheumatoid arthritis. Rheumatology 62, e4\u2013e6 (2022).","journal-title":"Rheumatology"},{"key":"1190_CR249","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00296-012-2365-9","volume":"33","author":"JS Oh","year":"2013","unstructured":"Oh, J. S. et al. The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells. Rheumatol. Int. 33, 381\u2013388 (2013).","journal-title":"Rheumatol. Int."},{"key":"1190_CR250","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1139\/Y09-094","volume":"88","author":"TY Wang","year":"2010","unstructured":"Wang, T. Y. et al. Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+CD25+ regulatory T cells. Can. J. Physiol. Pharmacol. 88, 45\u201353 (2010).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"1190_CR251","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5114\/ceji.2014.43714","volume":"39","author":"M Zhu","year":"2014","unstructured":"Zhu, M., Xu, Q., Li, X. L., He, Q. & Wang, W. F. Modulating effects of leflunomide on the balance of Th17\/Treg cells in collagen-induced arthritis DBA\/1 mice. Cent. Eur. J. Immunol. 39, 152\u2013158 (2014).","journal-title":"Cent. Eur. J. Immunol."},{"key":"1190_CR252","doi-asserted-by":"publisher","first-page":"108877","DOI":"10.1016\/j.clim.2021.108877","volume":"233","author":"CA Bounia","year":"2021","unstructured":"Bounia, C. A. & Liossis, S. C. B cell depletion treatment decreases Th17 cells in patients with rheumatoid arthritis. Clin. Immunol. 233, 108877 (2021).","journal-title":"Clin. Immunol."},{"key":"1190_CR253","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/art.30314","volume":"63","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk, F. L. et al. The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum. 63, 1507\u20131516 (2011).","journal-title":"Arthritis Rheum."},{"key":"1190_CR254","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","volume":"123","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis, P. P. et al. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin. Immunol. 123, 66\u201373 (2007).","journal-title":"Clin. Immunol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01190-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T09:03:28Z","timestamp":1734685408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01190-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":254,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01190-w","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"6 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.A.H. has received salary support from the Childhood Arthritis and Rheumatology Research Alliance (CARRA); investigator-initiated research grants from BMS; and consulting fees from Sobi, Pfizer and Adaptive Biotechnologies. F.v.W. has previously served as a speaker and\/or consultant for Janssen, Johnson & Johnson and Takeda, and has received grants from Regeneron Pharmaceuticals, LEO Pharma, Sanofi, BMS, Galapagos and Takeda. P.A.N. declares consulting relationships with Alkermes, Apollo, BMS, Exo Therapeutics, Fresh Tracks Therapeutics, Merck, Novartis, Pfizer, Qiagen and Sobi; equity in Edelweiss Immune Inc.; investigator-initiated research grants from BMS and Pfizer; and authorship and editorial income from UpToDate, the American Academy of Paediatrics and Arthritis & Rheumatology. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}